Our fully-automated digital image analysis technology enables to evaluate the efficacy of your lead molecules with more reliability, more accuracy and less variability than traditional scoring method. #EASL #ILC2019 #Liver

We are attending the International Liver Congress. Today is full of meetings, but if you want to meet us, we can book a slot ! #ILC2019 #EASL #Liver #NASH #NAFLD #Digital #Imaging #Histology

Tomorrow, we will present a poster with Pr. Isabelle Leclercq from University of Louvain about #NAFLD / #NASH at the International Liver Congress in Vienna. #ILC19 #ILC2019 #EASL #Liver #disease

That's great news for us ! Discover our other public references by clicking on the picture : biocellvia.com/references #reference #startup #client #pharma #biotech #medtech #NASH #IPF #ILC19 #liver #lung #pulmonary #fibrosis #fatty #disease

I’ll be speaking today at #NASHSummit in Boston on “Understanding HCC as an extension of NASH: practical implications for drug development”. Hope to see some of you there! #HCC #NASH

That's great news for us ! Discover our other public references by clicking on the picture : biocellvia.com/references #reference #startup #biotech #medtech #NASH #NAFLD #NashSummit #EASL #ILC2019 #pharma #liver #disease

Olivier Julé presented yesterday Biocellvia's fundraising activity in Paris in front of dozens of investors and business angels. To invest in Biocellvia : lnkd.in/gdbvkgR #startup #fundraising #equity #crowdequity #crowdfunding #invest #investment #biotech #medtech

We’ve already announced three new references since the beginning of the year... And there’s more coming! lnkd.in/gqxp2cK

You can invest in Biocellvia with Sowefund by clicking here : sowefund.com/projet/69/bioc… #crowdequity #fundraising #crowdfunding #funding #startup #biotech #medtech #pharma #frenchtech #tech

Rejoignez l'aventure Biocellvia et investissez à partir de 100€ dans cette #startup #biotech sur Sowefund : urlz.fr/97jK

Biocellvia met today leaders from Californian pharma companies. That was a great moment ! #innovation #tech #pharma #startup #medtech #biotech #histology #digital #image #analysis #health

Thanks a lot ENYO Pharma

Our article on the digital analysis of Idiopathic Pulmonary Fibrosis (IPF) is often quoted. There has been a significant impact which is yet another sign the scientific community is interested in our technology. More info on : lnkd.in/gD5CVFS

We are doing a NASH quantitative analysis by quantifying with considerable accuracy the three key parameters of this pathology: steatosis, fibrosis and inflammation. More info on : biocellvia.com #EASL #AASLD #ILC2019 #NASH #NAFLD #steatosis #fibrosis #inflammation

On this International NASH Day, Biocellvia wants to highlight its own involvment in the research to fight this disease. More info on : lnkd.in/gRvWq6F #NASH #NASHdisease #InternationalNASHday #NAFLD #NASHday #liver #biotech #medtech #pharma #obesity #diabete #startup

Thanks a lot CCI Provence-Alpes-Côte d'Azur for this nice article about Biocellvia #startup #medtech #biotech #technology #innovation #science #biology #invest #investment #equity #crowdequity

ELPA president Marko is part of Paris #NASH meeting. He will address to the participants in panel 1, session 1 on patient view of #NAFLD and #NASH. The NASH Education Program @intNASHday NASH24x7 EU One Health WHO/Europe

Prof. Serfaty addressing the participants of Paris #NASHmeeting. Marko #NAFLD #NASH. The NASH Education Program @intNASHday NASH24x7 EU One Health WHO/Europe

Phil Newsome describing strategies to treat Liver fibrosis. So many similarities with trying to #CureIPF. List of current therapies being tried in NASH & NAFLD. ?roles in #IPF. Also more good news about #coffee!

Vous pouvez toujours investir dans la startup Biocellvia, découvrez le dernier article des Les Echos sur cette #biotech #startup #entrepreneuriat #crowdfunding